| Financial Year |
March 31 2023 |
| Monetary Funds |
8,162,311,756.92 |
| Held-for-trading Financial Assets |
14,622,520.55 |
| Notes Receivable |
1,220,328.65 |
| Accounts Receivable |
852,460,495.03 |
| Advances to Suppliers |
287,438,405.96 |
| Other Receivables |
4,000,361,519.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
87,651,664.06 |
| Inventories |
22,103,156,682.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
15,813,871.52 |
| Other Current Assets |
2,119,711,012.72 |
| Total Current Assets |
37,679,059,566.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
6,458,544.44 |
| Long-term Equity Investment |
3,930,588,570.40 |
| Investment Properties |
9,273,049,801.27 |
| Fixed Assetes |
4,867,127,244.02 |
| Under-construction Projects |
4,999,970,586.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,456,525,513.35 |
| R&D expenses |
-- |
| Goodwill |
11,133,118.55 |
| Long-Term Deferred and Prepaid Expenses |
71,658,307.98 |
| Deferred Income Tax Assets |
274,717,289.61 |
| Other Non-Current Assets |
849,074,310.91 |
| Sub-Total of Non-Current Assets |
30,945,524,484.57 |
| Total Assets |
68,624,584,051.48 |
| Short-Term Loans |
1,689,092,996.80 |
| Trading Financial liabilities |
-- |
| Notes Payable |
46,521,349.93 |
| Accounts Payable |
4,552,563,999.01 |
| Accounts Received In Advance |
24,541,007.44 |
| Employee Compensation Payable |
172,463,590.49 |
| Taxes Payable |
492,852,645.68 |
| Interest Payable |
-- |
| Dividend Payable |
12,704,349.55 |
| Other payables |
4,896,121,914.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,060,108,033.56 |
| Other Current Liabilities |
4,521,766,382.68 |
| Sub-Total of Current Liabilities |
28,156,583,262.47 |
| Long-term Loans |
17,783,689,015.38 |
| Bonds Payable |
1,500,000,000.00 |
| Long-Term Accounts Payable |
3,162,963.90 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,850,000.00 |
| Deferred Income Tax Liabilities |
419,352,991.57 |
| Other Non-Current Liabilities |
1,776,328,755.65 |
| Sub-Total of Non-Current Liabilities |
22,066,049,596.86 |
| Total Liabilities |
50,222,632,859.33 |
| Paid-In Capital(Or Share Stock) |
2,707,782,513.00 |
| Capital Surplus |
1,947,708,463.48 |
| Surplus Reserve |
343,528,008.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,330,107,677.96 |
| Minority Stockholder's Interest |
8,081,447,549.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,320,503,642.64 |
| Owner's Equity（Stockholder's Equity） |
18,401,951,192.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
68,624,584,051.48 |
